ArticleFrontiers in public health2026
Anxiety and depressive disorders in adolescent injury prevention and safety promotion: frontier and inequality mapping across 953 locations.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
30 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Anxiety and depressive disorders constitute major contributors to global mental health burdens, disproportionately affecting 10-24-year-olds during critical neurodevelopmental windows. Despite their substantial disease burden, persistent treatment gaps and inequitable resource allocation remain worldwide. This study aims to systematically examine the evolving disease burden, inequalities, and achievable frontiers for anxiety and depressive disorders among 10-24 years from 1990 to 2021, providing critical epidemiological evidence to inform integrated adolescent mental health and injury prevention strategies. Methods: Employed the data from the Global Burden of Disease Study (GBD) 2021, this study analyzed anxiety and depressive indicators across 953 locations at global, regional, national, and subnational levels, with stratification by sociodemographic index (SDI) quintiles to examine socioeconomic inequalities and identify potentially achievable frontiers. Data analysis occurred from August 2024 to January 2025. Results: Key findings reveal a marginal increase in incidence rates over three decades, driven by a marked surge during the pandemic. Significant inter-regional disparities emerged, with high SDI regions such as Western Europe and High-income North America bearing disproportionately greater burdens. Notably, while some countries like Pakistan and Nigeria demonstrated relatively low burdens, subnational analyses uncovered accelerated disease trajectories and persistent health inequities, underscoring emerging challenges in resource-constrained settings. Among the top 100 affected subnational locations in 2021, Iran (31%), Brazil (27%), and Italy (19%) recorded the highest anxiety DALY rates, while the United States of America (51%), the United Kingdom (25%), and Iran (19%) dominated depressive DALYs. Socioeconomic inequalities in disease burdens intensified globally from 1990 to 2021, most pronounced in high SDI countries. In 2021, 89.2% and 92.2% of 204 countries and territories fell behind the anxiety and depressive DALYs frontiers respectively, with 99.0% and 97.1% experiencing an increasing frontier deviation between 1990 and 2021. Among 494 subnational locations, 49.2% fell behind the anxiety DALYs frontiers, and 35.8% fell behind the depressive DALYs. Conclusion: These findings emphasize the urgency of implementing targeted interventions addressing developmental-stage vulnerabilities, and integrating equity-focused strategies into mental health prevention and promotion policy frameworks, with direct implications for adolescent self-harm prevention and child safety promotion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.